Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.36
+0.63 (7.22%)
Nov 21, 2024, 12:14 PM EST - Market open
Phathom Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 640 | 523 | 462 | 596 | 936 | 764 | |
| Market Cap Growth | 109.61% | 13.23% | -22.48% | -36.35% | 22.51% | - | |
| Enterprise Value | 781 | 535 | 464 | 461 | 758 | 807 | |
| Last Close Price | 8.73 | 9.13 | 11.22 | 19.67 | 33.22 | 31.14 | |
| PS Ratio | 19.86 | 766.44 | - | - | - | - | |
| PB Ratio | -6.60 | -7.18 | -6.17 | 8.25 | 4.82 | 3.35 | |
| P/TBV Ratio | - | - | - | 8.25 | 4.82 | 3.35 | |
| EV/Sales Ratio | 29.74 | 785.10 | - | - | - | - | |
| Debt / Equity Ratio | -2.77 | -6.13 | -2.76 | 1.27 | 0.25 | 0.10 | |
| Asset Turnover | 0.08 | 0.00 | - | - | - | - | |
| Quick Ratio | 5.45 | 9.88 | 5.92 | 9.69 | 5.18 | 65.04 | |
| Current Ratio | 5.73 | 10.25 | 6.12 | 9.86 | 5.25 | 68.20 | |
| Return on Equity (ROE) | - | - | - | -108.01% | -61.14% | -225.11% | |
| Return on Assets (ROA) | -57.67% | -36.14% | -60.85% | -34.85% | -28.44% | -13.23% | |
| Return on Capital (ROIC) | -66.59% | -41.42% | -73.00% | -41.51% | -31.75% | -13.54% | |
| Earnings Yield | -56.86% | -38.57% | -42.83% | -24.16% | -13.79% | -33.40% | |
| FCF Yield | -41.50% | -26.63% | -31.97% | -24.98% | -7.56% | -4.80% | |
| Buyback Yield / Dilution | -26.36% | -31.11% | -5.72% | -11.36% | -192.32% | -87.83% | |
| Total Shareholder Return | -26.36% | -31.11% | -5.72% | -11.36% | -192.32% | -87.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.